Clinical Trial

Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled multicenter clinical trial targeting subjects with moderate to severe plaque psoriasis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-12.
Status change: Not Yet Recruiting → Recruiting 2025-12-07
Trial Details
NCT Number NCT07130604
Lead Sponsor InventisBio Co., Ltd
Conditions Plaque Psoriasis
Enrollment 390 participants
Start Date 2025-09-18
Primary Completion 2027-07-28 (estimated)
Study Completion 2027-07-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-09